Skip to main content
Labbieux
Back to PHDP5

Research library

Explore selected publications, evidence types, key findings, and registered studies with direct links to each primary record. This curated library is not a complete archive of the thousands of studies across the wider scientific literature.

PublicationsClinical trials

2 publications

Showing records relevant to PHDP5.

Preclinical animal

The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer's disease model mice.

Key finding

The study reports that in contrast, mice treated with a scrambled construct (FITC-SPHDP5-CPP) showed no significant improvement.

Brain research 2024

Direct PHDP5 evidence. Relevant to PHDP5

PubMed
Review

Therapeutic potential of small peptides in Alzheimer's disease: Advances in memory restoration and targeted delivery systems.

Key finding

The study reports that when combined with advanced delivery systems, small peptides hold significant promise for mitigating synaptic dysfunction and slowing the progression of Alzheimer's disease.

Neuropeptides 2025

Research relevant to PHDP5. Relevant to PHDP5

PubMed

This library supports source-led professional evaluation. Product-specific clinical and regulatory guidance provides the framework for interpreting the records in context.

Browse all products